Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays.

نویسندگان

  • Jacques P Brown
  • Suzanne Morin
  • William Leslie
  • Alexandra Papaioannou
  • Angela M Cheung
  • Kenneth S Davison
  • David Goltzman
  • David Arthur Hanley
  • Anthony Hodsman
  • Robert Josse
  • Algis Jovaisas
  • Angela Juby
  • Stephanie Kaiser
  • Andrew Karaplis
  • David Kendler
  • Aliya Khan
  • Daniel Ngui
  • Wojciech Olszynski
  • Louis-Georges Ste-Marie
  • Jonathan Adachi
چکیده

OBJECTIVE To outline the efficacy and risks of bisphosphonate therapy for the management of osteoporosis and describe which patients might be eligible for bisphosphonate "drug holiday." QUALITY OF EVIDENCE MEDLINE (PubMed, through December 31, 2012) was used to identify relevant publications for inclusion. Most of the evidence cited is level II evidence (non-randomized, cohort, and other comparisons trials). MAIN MESSAGE The antifracture efficacy of approved first-line bisphosphonates has been proven in randomized controlled clinical trials. However, with more extensive and prolonged clinical use of bisphosphonates, associations have been reported between their administration and the occurrence of rare, but serious, adverse events. Osteonecrosis of the jaw and atypical subtrochanteric and diaphyseal femur fractures might be related to the use of bisphosphonates in osteoporosis, but they are exceedingly rare and they often occur with other comorbidities or concomitant medication use. Drug holidays should only be considered in low-risk patients and in select patients at moderate risk of fracture after 3 to 5 years of therapy. CONCLUSION When bisphosphonates are prescribed to patients at high risk of fracture, their antifracture benefits considerably outweigh their potential for harm. For patients taking bisphosphonates for 3 to 5 years, reassess the need for ongoing therapy.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

How Long to Treat with Bisphosphonates?

Bisphosphonate class of drugs, the most commonly prescribed for the treatment of osteoporosis, is effective in preventing and treating bone loss and fractures. However, the treatment duration and the applicability of “drug holidays” for bisphosphonates need optimization in order to minimize long-term exposure. Drug holidays may prevent potential adverse events while still maintaining some degre...

متن کامل

Use of drug holidays in women taking bisphosphonates.

Bisphosphonates are the cornerstone of treatment for osteoporosis. These agents are generally safe and well-tolerated, but concerns have emerged about adverse effects related to long-term use, namely osteonecrosis of the jaw and atypical femur fractures. For most patients at moderate or high risk of fracture, the benefits of treatment far outweigh these serious but rare risks. Bisphosphonates a...

متن کامل

Underdiagnosis and Undertreatment of Osteoporosis: The Battle to Be Won.

CONTEXT An expert opinion perspective on why osteoporosis is underdiagnosed and undertreated. OBJECTIVE To highlight the potential reasons for why osteoporosis is undertreated. DESIGN Literature review from PubMed, Plos One, and Science Direct search engines from 1900-2015 under terms: sub-trochanteric and atypical femur fractures, bisphosphonate clinical trial and bisphosphonate review art...

متن کامل

Optimizing orthodontic treatment in patients taking bisphosphonates for osteoporosis.

Bisphosphonates have unique pharmacological characteristics unlike those of any other drug group. Millions of adults take oral bisphosphonates for long-term treatment of osteoporosis and osteopenia; some of these people will most likely also seek orthodontic treatment. Adverse dental effects from bisphosphonates have been reported, including decreased tooth movement, impaired bone healing, and ...

متن کامل

The Effects of Marine Algae on Osteoporosis

Background: Osteoporosis is a prevalent bone disease caused by an imbalance between bone formation and resorption.  Nutritional factors are involved in the preven­tion of osteoporosis. Several treatments exist for osteoporosis including bisphosphonates, parathyroid hormone, estrogen therapy, and hormone therapy, which have their own side effects. In the quest for an appropriate treatment for os...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Canadian family physician Medecin de famille canadien

دوره 60 4  شماره 

صفحات  -

تاریخ انتشار 2014